Trademark: 88615918
Word
DESCOVY EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Status Date
Tuesday, July 13, 2021
Registration Number
6414007
Registration Date
Tuesday, July 13, 2021
Filing Date
Friday, September 13, 2019
Published for Opposition
Tuesday, November 3, 2020
5 Anti-viral pharmaceutical preparations; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment of immune dysfunction; pharmaceutical preparations for the treatment and prevention of human immunodeficiency virus infection; all of the foregoing containing emtricitabine and tenofovir alafenamide
44 Information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, namely, pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; providing medical information and advisory services regarding HIV infection
The color(s) blue, light blue, and black is/are claimed as a feature of the mark.
"EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS"
The mark consists of a blue diamond with an incomplete light blue diamond below it along with the word "DESCOVY" in blue to the right and the words "EMTRICITABINE 200 MG / TENOFOVIR ALAFENAMIDE 25MG TABLETS" in black beneath "DESCOVY". Appearing below is the stylized wording "FOR PREP PRE-EXPOSURE PROPHYLAXIS" with the wording "FOR" and "PRE-EXPOSURE PROPHYLAXIS" in light blue, and the word "PREP" contained within a blue oblong shaped pill design. All instances of the color white in the mark represent background and/or transparent areas only and are not features of the mark.
DESCOVY EMTRICITABINE TWO HUNDRED MILLIGRAMS / TENOFOVIR ALAFENAMIDE TWENTY FIVE MILLIGRAMS TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Jul 13, 2021
Registered-Principal Register
Jun 4, 2021
1(B) Basis Deleted; Proceed To Registration
May 3, 2021
Notice Of Allowance Cancelled
Jun 4, 2021
Case Assigned To Intent To Use Paralegal
May 3, 2021
Teas Delete 1(B) Basis Received
Dec 29, 2020
Noa E-Mailed - Sou Required From Applicant
Nov 3, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 3, 2020
Published For Opposition
Oct 14, 2020
Notification Of Notice Of Publication E-Mailed
Sep 29, 2020
Electronic Record Review Complete
Sep 25, 2020
On Hold - Electronic Record Review Required
Sep 22, 2020
Approved For Pub - Principal Register
Sep 22, 2020
Examiner's Amendment Entered
Sep 22, 2020
Notification Of Examiners Amendment E-Mailed
Sep 22, 2020
Examiners Amendment E-Mailed
Sep 22, 2020
Examiners Amendment -Written
Sep 1, 2020
Teas/Email Correspondence Entered
Sep 1, 2020
Correspondence Received In Law Office
Aug 26, 2020
Assigned To Lie
Aug 6, 2020
Teas Response To Office Action Received
Apr 6, 2020
Notification Of Non-Final Action E-Mailed
Apr 6, 2020
Non-Final Action E-Mailed
Apr 6, 2020
Non-Final Action Written
Mar 13, 2020
Teas/Email Correspondence Entered
Mar 12, 2020
Correspondence Received In Law Office
Mar 12, 2020
Teas Response To Office Action Received
Dec 21, 2019
Notification Of Non-Final Action E-Mailed
Dec 21, 2019
Non-Final Action E-Mailed
Dec 21, 2019
Non-Final Action Written
Dec 14, 2019
Assigned To Examiner
Sep 24, 2019
Notice Of Design Search Code E-Mailed
Sep 23, 2019
New Application Office Supplied Data Entered In Tram
Sep 17, 2019
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
